Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer
NCT ID: NCT01218490
Last Updated: 2019-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
PHASE3
450 participants
INTERVENTIONAL
2008-12-09
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lymphadenectomy In Ovarian Neoplasms
NCT00712218
LYmphadenectomy After NeoAdjuvant Chemotherapy
NCT01724944
Systematic Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer
NCT06385912
Long Term Survivors in Ovarian Cancer
NCT03128294
Lymphadenectomy in Early Ovarian Cancer
NCT04710797
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
lymphadenectomy
after surgery of the ovarian cancer, patient will have Pelvis and aortic-cava lymphadenectomy
ovarian cancer surgery
no lymphadectomy
after surgery, the patient will not have pelvic and aortic-cave lymphadenectomy
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ovarian cancer surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Karnofsky\> 80, or ASA I-II
* Primary ovarian adenocarcinoma, or primitive peritoneal
* No retroperitoneal lymph node\> 2cm (CT; MRI)
* Complete surgical staging
* Stage III-IV FIGO classification
* Indication of systemic chemotherapy before surgery or post surgery
Exclusion Criteria
* non-epithelial or borderline cancer
* Pregnancy
* Previous pelvic lymphadenectomy or aortic-cava for a disease other than ovarian cancer
* Contraindication to Platinum and Paclitaxel
* Borderline Ovarian Tumor
* tumor recurrence
* Incomplete surgery, resectable lesion, Surgery sub optimal (R\> 1cm)
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut Cancerologie de l'Ouest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique Sainte Thérèse
Amiens, , France
Centre Paul Papin
Angers, , France
Hospital
Angers, , France
Hospital
Brest, , France
Centre Jean Perrin
Clermont-Ferrand, , France
Centre G F Leclerc
Dijon, , France
Hospital
Lyon, , France
Institut Paoli Calmette
Marseille, , France
Centre Val d'Aurelle
Montpellier, , France
Hôpital Européen Georges Pompidou
Paris, , France
Hôpital Lariboisière
Paris, , France
Hôpital des Diaconesses
Paris, , France
Clinique Mutualiste
Rennes, , France
Hopital
Rennes, , France
Centre René Huguenin
Saint-Cloud, , France
Institut Cancerologie de l'Ouest
Saint-Herblain, , France
Centre Paul Strauss
Strasbourg, , France
Institut Claudius Regaud
Toulouse, , France
Hôpital Bretonneau
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SC 07/12-H
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.